Severe congenital malaria acquired in utero
- PMID: 20348499
- PMCID: PMC2844577
- DOI: 10.4269/ajtmh.2010.09-0744
Severe congenital malaria acquired in utero
Abstract
Vertical transmission of Plasmodium falciparum is under-recognized and usually associated with asymptomatic low-level parasitemia at birth. We report symptomatic congenital malaria presenting as a neonatal sepsis syndrome. The presence at birth of a high asexual parasitemia, gametocytemia, and splenomegaly indicated in utero rather than intrapartum transmission. The neonate was successfully treated with intravenous artesunate followed by oral dihydroartemisinin-piperaquine, without apparent adverse effects.
Similar articles
-
Highly effective therapy for maternal malaria associated with a lower risk of vertical transmission.J Infect Dis. 2011 Nov 15;204(10):1613-9. doi: 10.1093/infdis/jir558. Epub 2011 Sep 9. J Infect Dis. 2011. PMID: 21908728 Free PMC article.
-
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.Lancet. 2006 Jun 24;367(9528):2075-85. doi: 10.1016/S0140-6736(06)68931-9. Lancet. 2006. PMID: 16798391 Clinical Trial.
-
Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.BMC Infect Dis. 2019 Dec 3;19(1):1025. doi: 10.1186/s12879-019-4647-2. BMC Infect Dis. 2019. PMID: 31795967 Free PMC article. Clinical Trial.
-
Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.Southeast Asian J Trop Med Public Health. 2013;44 Suppl 1:201-30; discussion 306-7. Southeast Asian J Trop Med Public Health. 2013. PMID: 24159833 Review.
-
Artemisinin-based combination treatment of falciparum malaria.Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):181-92. Am J Trop Med Hyg. 2007. PMID: 18165491 Review.
Cited by
-
Diagnosing congenital malaria in a high-transmission setting: clinical relevance and usefulness of P. falciparum HRP2-based testing.Sci Rep. 2017 May 18;7(1):2080. doi: 10.1038/s41598-017-02173-6. Sci Rep. 2017. PMID: 28522856 Free PMC article.
-
Persistence, impacts and environmental drivers of covert infections in invertebrate hosts.Parasit Vectors. 2017 Nov 2;10(1):542. doi: 10.1186/s13071-017-2495-8. Parasit Vectors. 2017. PMID: 29096700 Free PMC article.
-
Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort study.Malar J. 2018 Apr 12;17(1):163. doi: 10.1186/s12936-018-2315-4. Malar J. 2018. PMID: 29650007 Free PMC article.
-
Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax.Trends Parasitol. 2012 Nov;28(11):522-9. doi: 10.1016/j.pt.2012.08.005. Epub 2012 Oct 5. Trends Parasitol. 2012. PMID: 23044287 Free PMC article. Review.
-
Imported congenital malaria caused by Plasmodium ovale: A case report.Ther Adv Infect Dis. 2024 Feb 2;11:20499361241229263. doi: 10.1177/20499361241229263. eCollection 2024 Jan-Dec. Ther Adv Infect Dis. 2024. PMID: 38312850 Free PMC article.
References
-
- Menendez C, Mayor A. Congenital malaria: the least known consequence of malaria in pregnancy. Semin Fetal Neonatal Med. 2007;12:207–213. - PubMed
-
- Larkin GL, Thuma PE. Congenital malaria in a hyperendemic area. Am J Trop Med Hyg. 1991;45:587–592. - PubMed
-
- Lehner PJ, Andrews CJ. Congenital malaria in Papua New Guinea. Trans R Soc Trop Med Hyg. 1988;82:822–826. - PubMed
-
- Vottier G, Arsac M, Farnoux C, Mariani-Kurkdjian P, Baud O, Aujard Y. Congenital malaria in neonates: two case reports and review of the literature. Acta Paediatr. 2008;97:505–508. - PubMed
-
- Malhotra I, Mungai P, Muchiri E, Kwiek JJ, Meshnick SR, King CL. Umbilical cord-blood infections with Plasmodium falciparum malaria are acquired antenatally in Kenya. J Infect Dis. 2006;194:176–183. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources